This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gregoire, L
Right arrow Articles by Lancaster, W D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gregoire, L
Right arrow Articles by Lancaster, W D

 Previous Article  |  Next Article 

J Clin Microbiol. 1989 December; 27(12): 2660-2665

Amplification of human papillomavirus DNA sequences by using conserved primers.

L Gregoire, M Arella, J Campione-Piccardo and W D Lancaster

Department of Microbiology and Immunology, University of Ottawa, Ontario.

ABSTRACT

The polymerase chain reaction has potential for use in the detection of small amounts of human papillomavirus (HPV) viral nucleic acids present in clinical specimens. However, new HPV types for which no probes exist would remain undetected by using type-specific primers for the polymerase chain reaction before hybridization. Primers corresponding to highly conserved HPV sequences may be useful for detecting low amounts of known HPV DNA as well as new HPV types. Here we analyze a pair of primers derived from conserved sequences within the E1 open reading frame for HPV sequence amplification by using the polymerase chain reaction. The longest perfect homology among HPV sequences is a 12-mer within the first exon of E1M. A region of conserved amino acids coded by the E1 open reading frame allowed the detection of another highly conserved region about 850 base pairs downstream. Two 21-mers derived from these conserved regions were used to amplify sequences from all HPV DNAs used as templates. The amplified DNA was shown to be specific for HPV sequences within the E1 open reading frame. DNA from HPVs whose sequences were not available were amplified by using these two primers. HPV DNA sequences in clinical specimens could also be amplified with the primers.


J Clin Microbiol. 1989 December; 27(12): 2660-2665




This article has been cited by other articles:

  • Fontaine, V., Mascaux, C., Weyn, C., Bernis, A., Celio, N., Lefevre, P., Kaufman, L., Garbar, C. (2007). Evaluation of Combined General Primer-Mediated PCR Sequencing and Type-Specific PCR Strategies for Determination of Human Papillomavirus Genotypes in Cervical Cell Specimens. J. Clin. Microbiol. 45: 928-934 [Abstract] [Full Text]  
  • Ha, P. K., Califano, J. A. (2004). THE ROLE OF HUMAN PAPILLOMAVIRUS IN ORAL CARCINOGENESIS. CROBM 15: 188-196 [Abstract] [Full Text]  
  • Keefe, K. A., Schell, M. J., Brewer, C., McHale, M., Brewster, W., Chapman, J. A., Rose, G. S., McMeeken, D. S., Lagerberg, W., Peng, Y.-M., Wilczynski, S. P., Anton-Culver, H., Meyskens, F. L., Berman, M. L. (2001). A Randomized, Double Blind, Phase III Trial Using Oral {beta}-Carotene Supplementation for Women with High-Grade Cervical Intraepithelial Neoplasia. Cancer Epidemiol. Biomarkers Prev. 10: 1029-1035 [Abstract] [Full Text]  
  • Cubie, H A, Seagar, A L, McGoogan, E, Whitehead, J, Brass, A, Arends, M J, Whitley, M W (2001). Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18. Mol. Pathol. 54: 24-29 [Abstract] [Full Text]  
  • Zazove, P., Reed, B. D., Gregoire, L., Ferenczy, A., Gorenflo, D. W., Lancaster, W. D. (1998). Low False-Negative Rate of PCR Analysis for Detecting Human Papillomavirus-Related Cervical Lesions. J. Clin. Microbiol. 36: 2708-2713 [Abstract] [Full Text]  
  • Maurer, T. A., Vin Christian, K., Kerschmann, R. L., Berzin, B., Palefsky, J. M., Payne, D., Tyring, S. K., Berger, T. G. (1997). Cutaneous Squamous Cell Carcinoma in Human Immunodeficiency Virus-Infected Patients: A Study of Epidemiologic Risk Factors, Human Papillomavirus, and p53 Expression. Arch Dermatol 133: 577-583 [Abstract]  
  • Zazove, P., Reed, B. D., Gregoire, L., Gorenflo, D. W., Lancaster, W. D., Ruffin, M. T. IV, Hruszczyk, J. (1993). Presence of Human Papillomavirus Infection of the Uterine Cervix as Determined by Different Detection Methods in a Low-Risk Community-Based Population. Arch Fam Med 2: 1250-1258 [Abstract]  
  • Meyer, L. M., Tyring, S. K., Little, W. P. (1991). Verrucous Cyst. Arch Dermatol 127: 1810-1812 [Abstract]  
  • Bauer, H. M., Ting, Y., Greer, C. E., Chambers, J. C., Tashiro, C. J., Chimera, J., Reingold, A., Manos, M. M. (1991). Genital Human Papillomavirus Infection in Female University Students as Determined by a PCR-Based Method. JAMA 265: 472-477 [Abstract]